Stay updated on Nivolumab vs. Everolimus in RCC: Clinical Trial
Sign up to get notified when there's something new on the Nivolumab vs. Everolimus in RCC: Clinical Trial page.
Latest updates to the Nivolumab vs. Everolimus in RCC: Clinical Trial page
- Check2 days agoChange DetectedRevision metadata updated from v3.3.3 to v3.3.4; this is a minor administrative update with no impact on study data or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check9 days agoChange DetectedThe Publications section now shows the CheckMate 025 quality‑of‑life article with an Erratum, replacing the previous non-Erratum citation.SummaryDifference0.0%
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedAdded a comprehensive list of Locations covering the United States, Canada, Australia, and Europe; removed the prior location blocks and the HHS Vulnerability Disclosure entry.SummaryDifference2%
- Check52 days agoChange DetectedPublication note updated to indicate PubMed-derived publications are automatically filled and may not be about the study, and the revision tag changed to v3.3.2 (from v3.2.0).SummaryDifference0.0%
- Check60 days agoChange DetectedRemoved the generic government funding/operating status notice from the page. This deletion does not affect the trial content or user actions.SummaryDifference0.1%
- Check74 days agoChange DetectedNo significant changes were detected in the study record between the screenshots; the core content (title, conditions, interventions, eligibility criteria, outcomes, and locations) appears unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
Stay in the know with updates to Nivolumab vs. Everolimus in RCC: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab vs. Everolimus in RCC: Clinical Trial page.